Dec. 09, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare ...

CAMBRIDGE, Mass., March 17, 2022 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with ...

Sept. 25, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare ...

20, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics ... for facioscapulohumeral muscular dystrophy (FSHD) during the Virtual Congress of the World Muscle Society. These results highlight progress ...

Additionally, Emerald and FSHD-TUG help capture key metrics in FSHD patients.” Fulcrum and AMRA Medical have developed a quantitative WB-MSK-MRI protocol and analysis algorithms to ...

Here’s how it works. In a time where business travel has come to a screeching halt due to the COVID-19 pandemic, Fulcrum Acoustic is now offering a virtual tour of its Whitinsville, MA factory. "Our ...

March 28, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company ... today announced that management will participate in a fireside chat at the Cantor Virtual Muscular Dystrophy Symposium ...

CAMBRIDGE, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with ...